Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

April 18, 2017

Study Completion Date

July 7, 2017

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

AquaBeam System

The AquaBeam system delivers a high-velocity saline stream under precise electromechanical control and live ultrasound guidance to ablate prostatic glandular tissue without the production of heat. The physician uses ultrasound imaging to plan the treatment contour and depth to define the treatment region. The AquaBeam ablates the target tissue, adhering to the pre-defined treatment zone.

Trial Locations (1)

387001

Muljibhai Patel Urological Hospital, Nadiād

Sponsors
All Listed Sponsors
lead

PROCEPT BioRobotics

INDUSTRY

NCT03125889 - Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II | Biotech Hunter | Biotech Hunter